RAC 1.53% $1.66 race oncology ltd

Whilst straight lining the trial costs may be a reasonable...

  1. 134 Posts.
    lightbulb Created with Sketch. 33
    Whilst straight lining the trial costs may be a reasonable surrogate I would imagine trial costs are front loaded and/or milestone/recruitment based so a bit more "lumpy" and hard to predict (particularly around recruitment). Just to manage expectations. Great if you get some guidance....
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.